Browse

Considering the fact that the production of 1 kg of output in the pharmaceutical sector has a higher environmental impact than the production of 1 kg of output in the chemical industry, this article examines the way in which the specific legislation of the EU regarding medicinal products is adapted to the legislative instruments for the assessment and control of the environmental risks posed by medicinal products for human use during their life cycle, from production and up to the end of their life cycle. The Euro...